$VRTX

AI 分析

生成於 May 11, 2026

AI Score
78/ 100
Buy$VRTX

Vertex Pharmaceuticals

$VRTXNASDAQHealthcareLarge-Cap

Vertex discovers and develops medicines for cystic fibrosis and other serious diseases.

Market Cap
$105.0B
Revenue (TTM)
$10.3B
+12.0%
Net Income (TTM)
$3.8B
+15.0%
EPS (TTM)
$14.80
P/E Ratio
28.0
Dividend Yield
0.0%
52-Week Range
$350-$500
Beta
0.42
Dimension Scores
Fundamental
80
Technical
72
Sentiment
76
Risk / Reward
78
Momentum
74
FundTechSentRiskMome
Financial Health
Profitability
85strong
Growth
77strong
Liquidity
86strong
Solvency
82strong
Efficiency
78strong

Valuation, technical analysis, investment thesis, risk assessment and more for $VRTX

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。